Cipaglucosidase alfa Active Not Recruiting Phase 3 Trials for Late-onset Pompe Disease Treatment

Indications	Status	Purpose	Phase
DBCOND0064718 (Late-onset Pompe Disease)	Active Not Recruiting	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT04138277	A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With LOPD	Cipaglucosidase alfa (DB16708) Miglustat (DB00419)